MDXG

SEC source: 0001376339-25-000023 · wk-form4_1741219382.xml · nonDerivative · entry 1

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 448,948

F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

SEC source: 0001376339-25-000021 · wk-form4_1741219161.xml · derivative · entry 3

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,432

Underlying: Common Stock · 36,891 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement..

SEC source: 0001376339-25-000021 · wk-form4_1741219161.xml · nonDerivative · entry 2

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 576,220

F2 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

SEC source: 0001376339-25-000021 · wk-form4_1741219161.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 529,781

F1 · shares: Represents the payout of shares as a result of the vesting of performance stock units (PSUs) for the performance period from January 1, 2022 to December 31, 2024. The PSUs were granted on April 8, 2022.

SEC source: 0001376339-25-000017 · wk-form4_1741218255.xml · derivative · entry 2

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,241

Underlying: Common Stock · 36,486 shares

Expires 2032-03-03

F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.

SEC source: 0001376339-25-000017 · wk-form4_1741218255.xml · nonDerivative · entry 1

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,773

F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

F2 · balance_after: Includes an aggregate of 6,915 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan.

SEC source: 0001376339-25-000025 · wk-form4_1741220002.xml · nonDerivative · entry 1

Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,271

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0001376339-25-000002 · wk-form4_1739918208.xml · nonDerivative · entry 1

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 403,019

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, in accordance with company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

F2 · balance_after: Includes an aggregate of 4,911 shares acquired on July 31, 2024 and January 31, 2025 pursuant to the MiMedx Group, Inc. Employee Stock Purchase Plan

SEC source: 0001376339-24-000067 · wk-form4_1734127313.xml · nonDerivative · entry 1

Maersk-Moller Kimberly · CIK 0002029167 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 267,382

F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

SEC source: 0001376339-24-000060 · wk-form4_1720648683.xml · nonDerivative · entry 1

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 147,929

F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units.

SEC source: 0001376339-24-000046 · wk-form4_1717705009.xml · nonDerivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,409

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000048 · wk-form4_1717705217.xml · nonDerivative · entry 1

Newton Todd · CIK 0001460878 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 384,162

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000052 · wk-form4_1717705812.xml · nonDerivative · entry 1

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,314

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000045 · wk-form4_1717704918.xml · nonDerivative · entry 1

Olson Tiffany · CIK 0001442172 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,988

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000049 · wk-form4_1717705314.xml · nonDerivative · entry 1

BIERMAN JAMES L · CIK 0001189534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,162

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000047 · wk-form4_1717705117.xml · nonDerivative · entry 1

BEHRENS M KATHLEEN · CIK 0001211701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,162

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000044 · wk-form4_1717704830.xml · nonDerivative · entry 1

PUHY DOROTHY E · CIK 0001200493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,988

F1 · shares: Represents annual restricted stock grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-24-000035 · wk-form4_1715294786.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 453,271

F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units

SEC source: 0001376339-24-000030 · wk-form4_1713994253.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 462,167

F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units.

SEC source: 0001376339-24-000028 · wk-form4_1712785389.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 471,063

F1 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units.

SEC source: 0001376339-24-000019 · wk-form4_1710542093.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,959

F1 · shares: shares withheld for payment of tax liability upon vesting of restricted stock units.

SEC source: 0001376339-24-000017 · wk-form4_1709681274.xml · nonDerivative · entry 2

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,340

F2 · shares: Shares withheld for payment of tax liability upon vesting of restricted stock units.

SEC source: 0001376339-24-000017 · wk-form4_1709681274.xml · derivative · entry 3

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,541

Underlying: Common Stock · 71,541 shares

Expires 2031-03-01

F3 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement..

SEC source: 0001376339-24-000017 · wk-form4_1709681274.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 515,691

F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

SEC source: 0001376339-24-000016 · wk-form4_1709681249.xml · derivative · entry 2

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,755

Underlying: Common Stock · 70,755 shares

Expires 2031-03-01

F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.

SEC source: 0001376339-24-000016 · wk-form4_1709681249.xml · nonDerivative · entry 1

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 459,528

F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

SEC source: 0001376339-24-000015 · wk-form4_1709681229.xml · derivative · entry 2

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,755

Underlying: Common Stock · 70,755 shares

Expires 2031-03-01

F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement.

SEC source: 0001376339-24-000015 · wk-form4_1709681229.xml · nonDerivative · entry 1

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,678

F1 · shares: Represents grant of restricted stock which vests fully on the third anniversary of the grant, subject to the reporting person's continued employment as specified in the Restricted Stock Unit Agreement.

SEC source: 0001376339-24-000004 · wk-form4_1708551614.xml · nonDerivative · entry 2

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 401,050

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0001376339-24-000004 · wk-form4_1708551614.xml · nonDerivative · entry 1

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 416,321

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0001376339-24-000002 · wk-form4_1708118497.xml · nonDerivative · entry 2

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 431,814

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0001376339-24-000002 · wk-form4_1708118497.xml · nonDerivative · entry 1

Whitlow Ricci S · CIK 0001798744 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 447,012

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0000950170-23-073331 · ownership.xml · derivative · entry 2

Falcon Fund 2 Holding Company, L.P. · CIK 0001817718 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 28,195,249 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.

F1 · derivative.exercise_date: On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.

F1 · derivative.expiration_date: On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.

F1 · balance_after: On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.

SEC source: 0000950170-23-073331 · ownership.xml · nonDerivative · entry 1

Falcon Fund 2 Holding Company, L.P. · CIK 0001817718 · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,195,249

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.

F1 · price: On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend.

SEC source: 0001376339-23-000071 · wk-form4_1700690463.xml · nonDerivative · entry 1

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,200

SEC source: 0001376339-23-000059 · wk-form4_1688681577.xml · derivative · entry 2

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,000

Underlying: Common Stock · 94,000 shares

Expires 2030-07-05

F2 · shares: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement

F2 · derivative.exercise_date: The options granted to the reporting person shall vest 25% on each anniversary of the grant date, subject to the reporting person's continued employment as specified in the Nonqualified Stock Option Agreement

SEC source: 0001376339-23-000059 · wk-form4_1688681577.xml · nonDerivative · entry 1

DOUG RICE · CIK 0001618861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,200

F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years.

SEC source: 0001376339-23-000048 · wk-form4_1687817422.xml · nonDerivative · entry 2

Capper Joseph H · CIK 0001456817 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

SEC source: 0001376339-23-000048 · wk-form4_1687817422.xml · nonDerivative · entry 1

Capper Joseph H · CIK 0001456817 · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,975

SEC source: 0001376339-23-000038 · wk-form4_1686867074.xml · nonDerivative · entry 1

HAWKINS WILLIAM A · CIK 0001106508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,219

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000037 · wk-form4_1686867050.xml · nonDerivative · entry 1

Newton Todd · CIK 0001460878 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 360,972

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000036 · wk-form4_1686867005.xml · nonDerivative · entry 1

LAURENCIN CATO T · CIK 0001444810 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,124

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000042 · wk-form4_1686867744.xml · nonDerivative · entry 1

BIERMAN JAMES L · CIK 0001189534 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,972

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000041 · wk-form4_1686867605.xml · nonDerivative · entry 1

BEHRENS M KATHLEEN · CIK 0001211701 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,972

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000039 · wk-form4_1686867095.xml · nonDerivative · entry 1

Giuliani Michael J · CIK 0001834000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,124

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000040 · wk-form4_1686867247.xml · nonDerivative · entry 1

GARDNER PHYLLIS · CIK 0001238646 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,024

F1 · shares: Represents annual restricted stock unit grant to non-employee directors. Grant is exempt under Rule 16b-3. The award vests upon the earlier of 12 months or the next annual meeting of shareholders.

SEC source: 0001376339-23-000031 · wf-form4_168436236626701.xml · nonDerivative · entry 2

Stein Robert Benjamin · CIK 0001597158 · President, Regenerative Med.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,803

F2 · price: The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $5.870 to $6.025, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.

SEC source: 0001376339-23-000031 · wf-form4_168436236626701.xml · nonDerivative · entry 1

Stein Robert Benjamin · CIK 0001597158 · President, Regenerative Med.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 328,168

F1 · price: The purchase price indicated is a weighted average purchase price. The corresponding shares were bought in multiple transactions at prices ranging from $6.120 to $6.190, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth herein.

SEC source: 0001376339-23-000030 · wf-form4_168393230325038.xml · nonDerivative · entry 1

Hulse William Frank IV · CIK 0001796044 · General Counsel and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 456,564

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.

SEC source: 0001376339-23-000026 · wf-form4_168393199972917.xml · nonDerivative · entry 1

Phelan William Lawrence · CIK 0001811814 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 184,219

F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.